Search

Your search keyword '"Markopoulos, Christos"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Markopoulos, Christos" Remove constraint Author: "Markopoulos, Christos" Database Unpaywall Remove constraint Database: Unpaywall
127 results on '"Markopoulos, Christos"'

Search Results

1. Supplementary Figure S1 from Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial

2. Supplementary Figure S2 from Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial

7. Abstract P2-11-10: Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial

10. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing

15. Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer

16. Text mining and word embedding for classification of decision making variables in breast cancer surgery

17. Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

18. Abstract P1-12-01: Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: Final long-term results of the hellenic cooperative oncology group phase III HE10/05 trial

19. Abstract P2-09-10: Different CNVs account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing

21. Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients

25. Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study

26. Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer

28. Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

31. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

32. Theoretical and practical knowledge curriculum for European Breast Surgeons

34. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations

36. European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes

37. Pathway-based subnetworks enable cross-disease biomarker discovery

39. Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial

40. Network-Based Biomarkers Enable Cross-Disease Biomarker Discovery

41. Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center

43. Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial

45. Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial

47. Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy

48. The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

49. Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers.

50. Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

Catalog

Books, media, physical & digital resources